Loading stock data…
YI
$4.40-0.34 (-7.17%)
Market ClosedLast close Jun 9
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
111, Inc. in the Healthcare sector is trading at $4.40 with a market capitalization of $46M. The stock is currently 61% below its 52-week high of $11.17, remaining 19.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 22) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$4.40
Potential Downside
0%
Whystock Fair Value$4.40
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration servi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$46.27M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.66
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.45%
Volume
Today's trading volume
10,041
Recent News
Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading
Asian equities traded in the US as American depositary receipts were falling 2.14% Friday morning to
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
Asian equities traded in the US as American depositary receipts were tracking lower Wednesday mornin
Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading
Asian equities traded in the US as American depositary receipts were lower Monday morning, declining
Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading
Asian equities traded in the US as American depositary receipts were trending sharply lower Tuesday
Asian Equities Traded in the US as American Depositary Receipts Surge in Friday Trading; Up 5% for Week
Asian equities traded in the US as American depositary receipts were moving sharply higher Friday mo